Westwood Holdings Group Inc Alnylam Pharmaceuticals, Inc. Transaction History

Westwood Holdings Group Inc

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	SELL	$185.53 - $241.31 $916,518 - $1.19 Million	-4,940 Reduced 56.16%	3,856 $916,000
Q3 2022 Nov 14, 2022	SELL	$138.54 - $232.0 $1.04 Million - $1.73 Million	-7,477 Reduced 45.95%	8,796 $1.76 Million
Q2 2022 Aug 15, 2022	SELL	$120.42 - $169.29 $12,884 - $18,114	-107 Reduced 0.65%	16,273 $2.37 Million
Q1 2022 May 12, 2022	SELL	$127.18 - $173.91 $213,153 - $291,473	-1,676 Reduced 9.28%	16,380 $2.67 Million
Q4 2021 Feb 25, 2022	BUY	$159.56 - $209.29 $1.11 Million - $1.45 Million	6,928 Added 62.26%	18,056 $3.06 Million
Q3 2021 Nov 12, 2021	SELL	$169.75 - $207.73 $28,687 - $35,106	-169 Reduced 1.5%	11,128 $2.1 Million
Q2 2021 Aug 16, 2021	BUY	$128.63 - $176.89 $1.45 Million - $2 Million	11,297 New	11,297 $1.92 Million

644

109M

1.28M

1.21M

Ticker ALNY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 123,028,000
Market Cap $31.3B
Description
Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...

Get notified when there are updates to the investment portfolio of Westwood Holdings Group Inc, based on Form 13F filings with the SEC.

Stay updated on Westwood Holdings Group Inc with notifications on news.